Apheresis

Men and women, aged 18 to 75, who have been diagnosed with moderater-to-severe ulcerative colitis or Crohn's disease may be eligible to participate in a clinical research study.

• Click here for study information investigating apheresis as a possible treatment for ulcerative colitis and Crohn's disease.
• Click here for Q&A-Adacolumn Research Studies for ulcerative colitis and Crohn's disease.

For more information contact:

Dolly Walkup, R.N.
(919) 843-8105
dwalkup@med.unc.edu